Arcutis Biotherapeutics, Inc. ARQT Business Segments — Other segment expenses

Similar metrics at other companies

SYNAReportable Segment — Other segment expenses (3)

$800K-95.4%

RDDTReportable Segment — Other segment expenses

$1.07M+991%

PRMBReportable Segment — Other segment expense

$28.3M-52.8%

FGReportable Segment — Other operating expenses

$33M-19.5%

SLMReportable Segment — Other operating expenses

$12.48M+6.7%

ALHCReportable Segment — Other segment expenses

$21.91M-11.8%

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s business segments — other segment expenses?

Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — other segment expenses of $5.86M in Q1 2026.

How has Arcutis Biotherapeutics, Inc.'s business segments — other segment expenses changed year-over-year?

Arcutis Biotherapeutics, Inc.'s business segments — other segment expenses decreased by 18.4% year-over-year, from $7.19M to $5.86M.

What is the long-term trend for Arcutis Biotherapeutics, Inc.'s business segments — other segment expenses?

Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s business segments — other segment expenses has grown at a -22.8% compound annual growth rate (CAGR), from $53.1M to $24.41M.

What does business segments — other segment expenses mean?

Reflects miscellaneous operating costs incurred by the segment that are not categorized under direct cost of sales, R&D, or SG&A. These expenses typically include allocated corporate overhead or specific operational charges unique to the segment's business model.